PhD, MD, or master's degree preferred in biostatistics, statistics, data science, artificial intelligence, epidemiology, bioinformatics, computational biology, medicine, or a related field. The role will focus on building proprietary AI, machine-learning, and statistical models to predict clinical-trial outcomes and generate differentiated investment insights.